Notably, a third of reported RNF43 cancer variants comprise nonsense or frameshift mutations that prospectively yield expression of C‐terminally shortened RNF43 proteins for which functional consequences remain unknown (www.cBioportal.org; Giannakis et al, 2014; Forbes et al, 2015). This evidence concerns the gene RNF43 and cancer.